What is NDC 68462-696?

68462-696 is the product NDC for sugammadex, Sugammadex sodium 500 mg/5mL injection, solution, listed with the FDA by GLENMARK PHARMACEUTICALS INC., USA. It has 1 package NDC, shown above in 10- and 11-digit form.

GLENMARK PHARMACEUTICALS INC., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for sugammadex?

35 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

sugammadex NDC 68462-696 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-696Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0696Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-696-50	6846206965068462069650	10 VIAL, SINGLE-DOSE in 1 CARTON (68462-696-50) / 5 mL in 1 VIAL, SINGLE-DOSE (68462-696-05)Marketed from Jul 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): sugammadex
Generic name (nonproprietary): sugammadex
Active ingredients: Sugammadex sodium — 500 mg/5mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: GLENMARK PHARMACEUTICALS INC., USANDC labeler code 68462
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214364
Marketing start: Jul 28, 2026
Listing expires: Dec 31, 2027
Other FDA classes: gamma-Cyclodextrins (Chemical structure)
Identifiers: Product ID 68462-696_e7897fc1-4553-460c-a29b-0bc91cd9ca10SPL ID e7897fc1-4553-460c-a29b-0bc91cd9ca10SPL set ID e7897fc1-4553-460c-a29b-0bc91cd9ca10RxCUI 1726992, 1727000UNII ERJ6X2MXV7UPC 0368462695203, 0368462696507

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468462069650 followed by a unit qualifier and the quantity

Package 68462-0696-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2026.

Indications (excerpt from the label)

Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information . Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68462-696

What is NDC 68462-696?: 68462-696 is the product NDC for sugammadex, Sugammadex sodium 500 mg/5mL injection, solution, listed with the FDA by GLENMARK PHARMACEUTICALS INC., USA. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: sugammadex.
What is the active ingredient?: Sugammadex sodium.
Who is the labeler?: GLENMARK PHARMACEUTICALS INC., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for sugammadex?: 35 other product NDCs are listed under this name. See all sugammadex NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other sugammadex NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Accord Healthcare Inc.	16729-726	16729-0726-03
sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Accord Healthcare Inc.	16729-727	16729-0727-03
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Fosun Pharma USA Inc.	72266-268	72266-0268-10
sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Fosun Pharma USA Inc.	72266-269	72266-0269-10
Sugammadex	Sugammadex sodium 200 mg/2mL	InjectionIntravenous	B. Braun Medical Inc.	0264-8200	00264-8200-10
Sugammadex	Sugammadex sodium 100 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0641-6270	00641-6270-10
Sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3468	00781-3468-95
Sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Sandoz Inc	0781-3469	00781-3469-95
Sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Dr. Reddy's Laboratories Inc.	43598-924	43598-0924-26
Sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Dr. Reddy's Laboratories Inc.	43598-925	43598-0925-37

All 36 sugammadex NDCs

Other NDCs under ANDA 214364

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214364
Product	Strength	Form · route	Labeler	Product NDC
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-441
sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-442
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	GLENMARK PHARMACEUTICALS INC., USA	68462-695
sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Fosun Pharma USA Inc.	72266-268
sugammadex	Sugammadex sodium 500 mg/5mL	Injection, SolutionIntravenous	Fosun Pharma USA Inc.	72266-269